BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35222743)

  • 1. Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing Breast Cancer: A Systematic Review and Network Meta-Analysis.
    Raja V; Farajzadegan Z; Mansourian M; Ghasemi K; Aboutalebi MS; Nouri R; Mokarian F
    Dis Markers; 2022; 2022():4119345. PubMed ID: 35222743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple biomarker panels for early detection of breast cancer in peripheral blood.
    Zhang F; Deng Y; Drabier R
    Biomed Res Int; 2013; 2013():781618. PubMed ID: 24371830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Biomarkers; 2017 Mar; 22(2):157-164. PubMed ID: 27775427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis.
    Shamshirian A; Aref AR; Yip GW; Ebrahimi Warkiani M; Heydari K; Razavi Bazaz S; Hamzehgardeshi Z; Shamshirian D; Moosazadeh M; Alizadeh-Navaei R
    BMC Cancer; 2020 Oct; 20(1):1049. PubMed ID: 33129287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
    Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
    BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.
    Lacombe J; Mangé A; Bougnoux AC; Prassas I; Solassol J
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1834-42. PubMed ID: 24957886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
    Li S; Yang X; Yang J; Zhen J; Zhang D
    Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Digital Breast Tomosynthesis for Detecting Breast Cancer in the Diagnostic Setting: A Systematic Review and Meta-Analysis.
    Ko MJ; Park DA; Kim SH; Ko ES; Shin KH; Lim W; Kwak BS; Chang JM
    Korean J Radiol; 2021 Aug; 22(8):1240-1252. PubMed ID: 34047504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
    Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Nineteen Different Imaging Methods for Patients with Breast Cancer: a Network Meta-Analysis.
    Zhang XH; Xiao C
    Cell Physiol Biochem; 2018; 46(5):2041-2055. PubMed ID: 29723846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The accuracy of mammography screening for breast cancer: a Meta-analysis].
    Zhu C; Wang L; Du LB; Li J; Zhang J; Dai M; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Sep; 37(9):1296-1305. PubMed ID: 27655581
    [No Abstract]   [Full Text] [Related]  

  • 13. Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
    Canelo-Aybar C; Carrera L; Beltrán J; Posso M; Rigau D; Lebeau A; Gräwingholt A; Castells X; Langendam M; Pérez E; Giorgi Rossi P; Van Engen R; Parmelli E; Saz-Parkinson Z; Alonso-Coello P
    Cancer Med; 2021 Apr; 10(7):2191-2204. PubMed ID: 33675147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis.
    Noble M; Bruening W; Uhl S; Schoelles K
    Arch Gynecol Obstet; 2009 Jun; 279(6):881-90. PubMed ID: 19023581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
    Zhu X; Huang JM; Zhang K; Xia LJ; Feng L; Yang P; Zhang MY; Xiao W; Lin HX; Yu YH
    Clin Breast Cancer; 2018 Oct; 18(5):e985-e995. PubMed ID: 29983379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy.
    Shen M; Wang H; Wei K; Zhang J; You C
    Medicine (Baltimore); 2018 May; 97(19):e0577. PubMed ID: 29742692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer.
    Xiang W; Rao H; Zhou L
    Thorac Cancer; 2020 Jun; 11(6):1423-1432. PubMed ID: 32233072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.
    Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X
    Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening.
    Houssami N; Zackrisson S; Blazek K; Hunter K; Bernardi D; Lång K; Hofvind S
    Eur J Cancer; 2021 May; 148():14-23. PubMed ID: 33706172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Blood DNA Methylation Markers in Early Detection of Breast Cancer: A Systematic Literature Review.
    Guan Z; Yu H; Cuk K; Zhang Y; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):496-505. PubMed ID: 30487132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.